VRTX AS OF 12/31/2003

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

February 10, 2004

Accession Number

0000080255-04-000284

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →